Ionis Pharmaceuticals (IONS) Change in Intangibles (2020 - 2026)
Ionis Pharmaceuticals (IONS) recorded quarterly Change in Intangibles of $1.5 million in Q1 2026, up 8.86% quarter-over-quarter from $1.4 million in Q4 2025, and up 128.26% on a YoY basis from $651000.0 in Q1 2025.
Ionis Pharmaceuticals (IONS) Change in Intangibles (2020 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Change in Intangibles history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Change in Intangibles rose 128.26% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $6.5 million (up 44.69% YoY), while the FY2025 annual figure was $5.6 million, up 11.44% from the prior year.
- Change in Intangibles was $1.5 million for Q1 2026 at Ionis Pharmaceuticals, up from $1.4 million in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $14.0 million in Q2 2024 to a low of -$12.8 million in Q3 2024.
- Historically, Change in Intangibles has averaged $1.2 million across 5 years, with a median of $1.2 million in 2024.
- Biggest YoY gain for Change in Intangibles was 1222.05% in 2024; the steepest drop was 1259.09% in 2024.
- A 5-year view of Change in Intangibles shows it stood at $867000.0 in 2022, then declined by 11.19% to $770000.0 in 2023, then surged by 230.78% to $2.5 million in 2024, then plunged by 46.41% to $1.4 million in 2025, then climbed by 8.86% to $1.5 million in 2026.
- The last three Change in Intangibles figures came in at $1.5 million (Q1 2026), $1.4 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ionis Pharmaceuticals | 12.23 Bn | 10.31 Bn | 243.11 Mn | 1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.49 Mn |
| Mar 31, 2026 | 1.49 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 651,000.00 |
| Mar 31, 2025 | 651,000.00 |
| Dec 31, 2024 | 2.55 Mn |
| Dec 31, 2024 | 2.55 Mn |
| Sep 30, 2024 | -12.75 Mn |
| Sep 30, 2024 | -12.75 Mn |
| Jun 30, 2024 | 14.03 Mn |
| Jun 30, 2024 | 14.03 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 770,000.00 |
| Dec 31, 2023 | 770,000.00 |